Systematic Review of Prevalence and Predictors of Frailty in Individuals with Human Immunodeficiency Virus

Journal of the American Geriatrics Society

Volumn 64, Issue 5, 2016, Pages 1006-1014

  Levett, Tom J ^a   Cresswell, Fiona V ^b   Malik, Muzaffar A ^a   Fisher, Martin ^a   Wright, Juliet ^a  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

aging; frailty; HIV; prevalence

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL COUNT; COMORBIDITY; DEMOGRAPHY; EDUCATIONAL STATUS; ETHNICITY; FRAIL ELDERLY; FUNCTIONAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PREVALENCE; SOCIAL STATUS; SYSTEMATIC REVIEW; VIRUS LOAD; WEIGHT REDUCTION;

EID: 84990246410     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.14101     Document Type: Article

References (37)

1. Hasse B, Ledergerber B, Furrer H et al. Morbidity and aging in HIV-infected persons: The Swiss HIV cohort study. Clin Infect Dis 2011;53:1130–1139.
2. Erlandson KM, Allshouse AA, Jankowski CM et al. Risk factors for falls in HIV-infected persons. J Acquir Immune Defic Syndr 2012;61:484–489.
3. Oursler KK, Goulet JL, Crystal S et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: Results from the Veterans Aging Cohort Study. AIDS Patient Care STDS 2011;25:13–20.
4. Brothers TD, Rockwood K. Biologic aging, frailty, and age-related disease in chronic HIV infection. Curr Opin HIV AIDS 2014;9:412–418.
5. Fisher M, Cooper V. HIV and ageing: Premature ageing or premature conclusions? Curr Opin Infect Dis 2012;25:1–3.
6. Pathai S, Bajillan H, Landay AL et al. Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 2014;69A:833–842.
7. High KP, Brennan-Ing M, Clifford DB et al. HIV and aging: State of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012;60:S1–S18.
8. Mitnitski AB, Graham JE, Mogilner AJ et al. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr 2002;2:1–8.
9. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56A:146–156.
10. Song X, Mitnitski A, Rockwood K. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc 2010;58:681–687.
11. Clegg A, Young J, Iliffe S et al. Frailty in elderly people. Lancet 2013;381:752–762.
12. Morley JE, Vellas B, van Kan GA et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013;14:392–397.
13. Bouillon K, Kivimaki M, Hamer M et al. Measures of frailty in population-based studies: An overview. BMC Geriatr 2013;13:64.
14. Terzian AS, Holman S, Nathwani N et al. Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Womens Health (Larchmt) 2009;18:1965–1974.
15. Piggott DA, Muzaale AD, Mehta SH et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS ONE 2013;8:e54910.
16. Althoff KN, Jacobson LP, Cranston RD et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci 2014;69A:189–198.
17. Wells G, Shea B, O'Connell D et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomised Studies in Meta-Analyses [on-line]. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp Accessed September 22, 2014.
18. Erlandson KM, Allshouse AA, Jankowski CM et al. Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials 2012;13:324–334.
19. Ianas V, Berg E, Mohler MJ et al. Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Provid AIDS Care 2013;12:62–66.
20. Onen NF, Agbebi A, Shacham E et al. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 2009;59:346–352.
21. Pathai S, Gilbert C, Weiss HA et al. Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr 2013;62:43–51.
22. Dávila-De la Llave G, Parra-Guerra H, Tamez-Rivera O et al. Frailty in patients aged 50 and older with HIV/AIDS in Mexico. Eur Geriatr Med 2013;4:S75.
23. Greene M, Covinsky K, Valcour V et al. Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr 2015;69:161–167.
24. Desquilbet L, Jacobson LP, Fried LP et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007;62A:1279–1286.
25. Desquilbet L, Margolick JB, Fried LP et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009;50:299–306.
26. Desquilbet L, Jacobson LP, Fried LP et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci 2011;66A:1030–1038.
27. Sandkovsky U, Robertson KR, Meza JL et al. Pilot study of younger and older HIV-infected adults using traditional and novel functional assessments. HIV Clin Trials 2013;14:165–174.
28. Rodríguez-Mañas L, Féart C, Mann G et al. Searching for an operational definition of frailty: A Delphi method based consensus statement: The frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 2013;68A:62–67.
29. Collard RM, Boter H, Schoevers RA et al. Prevalence of frailty in community-dwelling older persons: A systematic review. J Am Geriatr Soc 2012;60:1487–1492.
30. Santos-Eggimann B, Cuénoud P, Spagnoli J et al. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol A Biol Sci Med Sci 2009;64A:675–681.
31. Piggott DA, Muzaale AD, Mehta SH et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS ONE 2013;8:e54910.
32. Saum K-U, Müller H, Stegmaier C et al. Development and evaluation of a modification of the Fried frailty criteria using population-independent cutpoints. J Am Geriatr Soc 2012;60:2110–2115.
33. Leng SX, Margolick JB. Understanding frailty, aging, and inflammation in HIV infection. Curr HIV/AIDS Rep 2015;12:25–32.
34. Piggott DA, Varadhan R, Mehta SH et al. Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use. J Gerontol A Biol Sci Med Sci 2015;70A:1542–1547.
35. Hubbard RE, O'Mahony MS, Savva GM et al. Inflammation and frailty measures in older people. J Cell Mol Med 2009;13:3103–3109.
36. Rothman MD, Leo-Summers L, Gill TM. Prognostic significance of potential frailty criteria. J Am Geriatr Soc 2008;56:2211–2216.
37. INSIGHT START Study Group, Lundgren JD, Babiker AG et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015;373:795–807.